Dynatronics (NASDAQ:DYNT) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.
Insider and Institutional Ownership
13.0% of Dynatronics shares are owned by institutional investors. Comparatively, 99.8% of Irhythm Technologies shares are owned by institutional investors. 44.0% of Dynatronics shares are owned by company insiders. Comparatively, 5.1% of Irhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
This table compares Dynatronics and Irhythm Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility & Risk
Dynatronics has a beta of -0.15, meaning that its share price is 115% less volatile than the S&P 500. Comparatively, Irhythm Technologies has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500.
Earnings & Valuation
This table compares Dynatronics and Irhythm Technologies’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Dynatronics||$64.42 million||0.32||-$1.60 million||($0.40)||-6.35|
|Irhythm Technologies||$98.51 million||20.42||-$29.42 million||($1.30)||-63.99|
Dynatronics has higher earnings, but lower revenue than Irhythm Technologies. Irhythm Technologies is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings and price targets for Dynatronics and Irhythm Technologies, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Dynatronics currently has a consensus price target of $4.50, suggesting a potential upside of 77.17%. Irhythm Technologies has a consensus price target of $92.71, suggesting a potential upside of 11.45%. Given Dynatronics’ stronger consensus rating and higher probable upside, equities analysts plainly believe Dynatronics is more favorable than Irhythm Technologies.
Dynatronics beats Irhythm Technologies on 9 of the 14 factors compared between the two stocks.
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.
About Irhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.